Indigo Acquisition (INAC) Cash & Equivalents (2025 - 2026)
Indigo Acquisition's (INAC) quarterly Cash & Equivalents came in at $458473.0 in Q1 2026, up 1661.33% YoY from $26030.0 in Q1 2025, and down 31.26% on a QoQ basis from $666920.0 in Q4 2025.
Analysis
Indigo Acquisition (INAC) Cash & Equivalents (2025 - 2026) Analysis & Trends
Indigo Acquisition (INAC) has 2 years of Cash & Equivalents data on file, last reported at $458473.0 in Q1 2026.
- Quarterly Cash & Equivalents rose 1661.33% year-over-year to $458473.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $458473.0 (up 1661.33% YoY) and the FY2025 annual result came in at $666920.0, changed N/A from the prior year.
- Cash & Equivalents retreated to $458473.0 in Q1 2026, from $666920.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $717051.0 in Q3 2025 to a low of $5771.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 250,000.00 |
| 3 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | 54,503.00 |
| 4 | Fifth Era Acquisition Corp I | 657.23 Mn | 657.23 Mn | - | 157,686.00 |
| 5 | Andretti Acquisition | 656.30 Mn | 656.30 Mn | - | 225,380.00 |
| 6 | Oxley Bridge Acquisition | 652.74 Mn | 652.74 Mn | - | 729,941.00 |
| 7 | Drugs Made In America Acquisition | 647.83 Mn | 647.83 Mn | - | 174,974.00 |
| 8 | Launch Two Acquisition | 621.00 Mn | 621.00 Mn | - | 23,197.00 |
| 9 | Launch One Acquisition | 620.42 Mn | 620.42 Mn | - | 321,957.00 |
| 10 | Indigo Acquisition | 152.12 Mn | 152.12 Mn | - | 379,862.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 379,862.00 |
| Mar 31, 2026 | 458,473.00 |
| Dec 31, 2025 | 666,920.00 |
| Sep 30, 2025 | 717,051.00 |
| Jun 30, 2025 | 5,771.00 |
| Mar 31, 2025 | 26,030.00 |